
Human papillomavirus vaccination: the United Kingdom’s recommendation and update on European licensure and efficacy data
Author(s) -
Rebecca Howell-Jones
Publication year - 2007
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.12.46.03309-en
Subject(s) - licensure , human papillomavirus , vaccination , family medicine , medicine , kingdom , human papillomavirus vaccine , political science , virology , medical education , cervical cancer , cancer , biology , gardasil , paleontology
The United Kingdom (UK) has announced that it will introduce a Human papillomavirus (HPV) vaccination programme for all 12- to 13-year-old girls starting in 2008, and will implement a catch-up campaign for girls up to 18 years old.